참고문헌
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395: 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
- Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020;20:533-534. https://doi.org/10.1016/S1473-3099(20)30120-1
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-273. https://doi.org/10.1038/s41586-020-2012-7
- Faria NR, Suchard MA, Rambaut A, Streicker DG, Lemey P. Simultaneously reconstructing viral cross-species transmission history and identifying the underlying constraints. Philos Trans R Soc Lond B Biol Sci 2013;368:20120196. https://doi.org/10.1098/rstb.2012.0196
- Luis AD, Hayman DT, O'Shea TJ, Cryan PM, Gilbert AT, Pulliam JR, et al. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special? Proc Biol Sci 2013;280:20122753.
- O'Shea TJ, Cryan PM, Cunningham AA, Fooks AR, Hayman DT, Luis AD, et al. Bat flight and zoonotic viruses. Emerg Infect Dis 2014;20:741-745. https://doi.org/10.3201/eid2005.130539
- Lau SK, Li KS, Huang Y, Shek CT, Tse H, Wang M, et al. Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol 2010;84: 2808-2819. https://doi.org/10.1128/JVI.02219-09
- Han HJ, Wen HL, Zhou CM, Chen FF, Luo LM, Liu JW, et al. Bats as reservoirs of severe emerging infectious diseases. Virus Res 2015;205:1-6. https://doi.org/10.1016/j.virusres.2015.05.006
- Chen L, Liu B, Yang J, Jin Q. DBatVir: the database of bat-associated viruses. Database (Oxford) 2014;2014:bau021. https://doi.org/10.1093/database/bau021
- Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. History is repeating itself: probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic. Infez Med 2020;28:3-5.
- Spinelli A, Pellino G. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg 2020;107:785-787. https://doi.org/10.1002/bjs.11627
- Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health 2020;13:1833-1839. https://doi.org/10.1016/j.jiph.2020.07.014
- Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med 2020;2:1069-1076. https://doi.org/10.1007/s42399-020-00363-4
- Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARSCoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91-95. https://doi.org/10.1016/j.ijid.2020.03.017
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335-337. https://doi.org/10.1016/S1470-2045(20)30096-6
- Benton DJ, Wrobel AG, Xu P, Roustan C, Martin SR, Rosenthal PB, et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 2020;588:327-330. https://doi.org/10.1038/s41586-020-2772-0
- Fuentes-Prior P. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. J Biol Chem 2021;296:100135. https://doi.org/10.1074/jbc.REV120.015980
- Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-280. https://doi.org/10.1016/j.cell.2020.02.052
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
- Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses 2011;3:920-940. https://doi.org/10.3390/v3060920
- Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620-2629. https://doi.org/10.1172/JCI137244
- Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020;92:791-796. https://doi.org/10.1002/jmv.25770
- Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846-848. https://doi.org/10.1007/s00134-020-05991-x
- Kanda N, Shimizu T, Tada Y, Watanabe S. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 2007;37:338-350. https://doi.org/10.1002/eji.200636420
- Lee EY, Lee ZH, Song YW. CXCL10 and autoimmune diseases. Autoimmun Rev 2009;8:379-383. https://doi.org/10.1016/j.autrev.2008.12.002
- Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020;11:6317. https://doi.org/10.1038/s41467-020-19741-6
- Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One 2021;16:e0245556. https://doi.org/10.1371/journal.pone.0245556
- Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguere T. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor. Prog Urol 2020;30:484-487. https://doi.org/10.1016/j.purol.2020.05.007
- Mollica V, Rizzo A, Massari F. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol 2020;16:2029-2033. https://doi.org/10.2217/fon-2020-0571
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. https://doi.org/10.3322/caac.21492
- Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol 2004;203:631-637. https://doi.org/10.1002/path.1570
- Howard EE, Margolis LM, Berryman CE, Lieberman HR, Karl JP, Young AJ, et al. Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit. Am J Physiol Endocrinol Metab 2020;319: E678-E688. https://doi.org/10.1152/ajpendo.00157.2020
- Lucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD, et al. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov 2014;4:1310-1325. https://doi.org/10.1158/2159-8290.CD-13-1010
- Lucas JM, True L, Hawley S, Matsumura M, Morrissey C, Vessella R, et al. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J Pathol 2008;215:118-125. https://doi.org/10.1002/path.2330
- Hoang T, Nguyen TQ, Tran TA. Genetic susceptibility of ACE2 and TMPRSS2 in six common cancers and possible impacts on COVID-19. Cancer Res Treat 2021;53:650-656. https://doi.org/10.4143/crt.2020.950
- Kalkanli A, Kirkik D, Bostanci E, Tas SK. The important role of TMPRSS2 gene in COVID-19 and prostate cancer: in silico approach. Braz Arch Biol Technol 20021;64:11.
- Zhang T, Tseng C, Zhang Y, Sirin O, Corn PG, Li-Ning-Tapia EM, et al. CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment. Nat Commun 2016;7:11674. https://doi.org/10.1038/ncomms11674
- Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224-2234. https://doi.org/10.1182/blood-2004-03-1109
- Alassaf E, Mueller A. The role of PKC in CXCL8 and CXCL10 directed prostate, breast and leukemic cancer cell migration. Eur J Pharmacol 2020;886:173453. https://doi.org/10.1016/j.ejphar.2020.173453
- Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 2020;48:W509-W514. https://doi.org/10.1093/nar/gkaa407
- Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 2017;19:649-658. https://doi.org/10.1016/j.neo.2017.05.002
- Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 2019;47:W556-W560. https://doi.org/10.1093/nar/gkz430
- Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012;2:401-404. https://doi.org/10.1158/2159-8290.CD-12-0095
- Boyer JL. The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. Toxicol Sci 2006;92:587-595. https://doi.org/10.1093/toxsci/kfl008
- Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 2017;45:D362-D368. https://doi.org/10.1093/nar/gkw937
- Koster J, Volckmann R, Zwijnenburg D, Molenaar P, Versteeg R. Abstract 2490: R2: Genomics analysis and visualization platform. Cancer Res 2019;79(13 Suppl):2490. https://doi.org/10.1158/1538-7445.AM2019-2490
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323:2052-2059. https://doi.org/10.1001/jama.2020.6775
- Satue-Gracia EM, Vila-Corcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gomez-Bertomeu F, et al. Susceptibility and risk of SARS-CoV-2 infection among middle-aged and older adults in Tarragona area, Spain. Med Clin (Barc) 2022;158:251-259. https://doi.org/10.1016/j.medcli.2021.03.027
- ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Camara R, et al. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2020 Jul 30 [Epub]. https://doi.org/10.1016/j.hemonc.2020.07.005.
- Salunke AA, Nandy K, Pathak SK, Shah J, Kamani M, Kottakota V, et al. Impact of COVID-19 in cancer patients on severity of disease and fatal outcomes: a systematic review and meta-analysis. Diabetes Metab Syndr 2020;14:1431-1437. https://doi.org/10.1016/j.dsx.2020.07.037
- Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, et al. COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway. Front Oncol 2021;11:652535. https://doi.org/10.3389/fonc.2021.652535
- Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm: what we know so far. Front Immunol 2020;11:1446. https://doi.org/10.3389/fimmu.2020.01446
- Turnquist C, Ryan BM, Horikawa I, Harris BT, Harris CC. Cytokine storms in cancer and COVID-19. Cancer Cell 2020;38:598-601. https://doi.org/10.1016/j.ccell.2020.09.019
- Liu Y, Zhang C, Huang F, Yang Y, Wang F, Yuan J, et al. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Natl Sci Rev 2020;7:1003-1011. https://doi.org/10.1093/nsr/nwaa037
- Wightman SC, Uppal A, Pitroda SP, Ganai S, Burnette B, Stack M, et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br J Cancer 2015;113:327-335. https://doi.org/10.1038/bjc.2015.193
- Gwak J, Jeong H, Lee K, Shin JY, Sim T, Na J, et al. SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer. Cancers (Basel) 2020;12:2718. https://doi.org/10.3390/cancers12092718
- Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol 2010;176:2986-2996. https://doi.org/10.2353/ajpath.2010.090665
- Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020;80:e14-e18.
- Ioannidis JP, Axfors C, Contopoulos-Ioannidis DG. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters. Environ Res 2020;188:109890. https://doi.org/10.1016/j.envres.2020.109890
- Peng J, Sun J, Zhao J, Deng X, Guo F, Chen L. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells. J Transl Med 2021;19:358. https://doi.org/10.1186/s12967-021-03037-4
- Schuler BA, Habermann AC, Plosa EJ, Taylor CJ, Jetter C, Negretti NM, et al. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. J Clin Invest 2021;131:e140766. https://doi.org/10.1172/JCI140766
- Arora K, Barbieri CE. Molecular subtypes of prostate cancer. Curr Oncol Rep 2018;20:58. https://doi.org/10.1007/s11912-018-0707-9
- Ren S, Wei GH, Liu D, Wang L, Hou Y, Zhu S, et al. Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression. Eur Urol 2018;73:322-339. https://doi.org/10.1016/j.eururo.2017.08.027
- Qiu J, Chen K, Zhong C, Zhu S, Ma X. Network-based protein-protein interaction prediction method maps perturbations of cancer interactome. PLoS Genet 2021;17:e1009869. https://doi.org/10.1371/journal.pgen.1009869
- Losuwannarak N, Maiuthed A, Kitkumthorn N, Leelahavanichkul A, Roytrakul S, Chanvorachote P. Gigantol targets cancer stem cells and destabilizes tumors via the suppression of the PI3K/AKT and JAK/STAT pathways in ectopic lung cancer xenografts. Cancers (Basel) 2019;11:2032. https://doi.org/10.3390/cancers11122032
- Rezaei-Tavirani M, Rezaei-Taviran S, Mansouri M, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pac J Cancer Prev 2017;18:3357-3363.
- Bhowmick NA, Oft J, Dorff T, Pal S, Agarwal N, Figlin RA, et al. COVID-19 and androgen-targeted therapy for prostate cancer patients. Endocr Relat Cancer 2020;27:R281-R292. https://doi.org/10.1530/ERC-20-0165
- Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532). Ann Oncol 2020;31:1040-1045. https://doi.org/10.1016/j.annonc.2020.04.479
- Shimizu M. Clinical features of cytokine storm syndrome. In: Cytokine Storm Syndrome (Cron RQ, Behrens EM, eds.). Cham: Springer International Publishing, 2019. pp. 31-41.